Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Journavx
Pharma
As Vertex's pain launch gains more use, sales just missed in Q3
Sales for three key launch products for Vertex came up short of expectations in the third quarter, including for non-opioid pain reliever Journavx.
Kevin Dunleavy
Nov 4, 2025 8:40am
Gilead, Eisai, Vertex meds make Time's list of best inventions
Oct 10, 2025 11:58am
Vertex signs up NBA All-Star Jayson Tatum to promote Journavx
Sep 24, 2025 10:30am
Vertex narrows development plan for non-opioid pain med Journavx
Aug 5, 2025 10:55am
Vertex's international sales slide with IP 'violation' in Russia
May 6, 2025 2:23pm
Vertex drafts NFL alum Alex Smith for unbranded pain campaign
May 1, 2025 3:58pm